• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Report: Insulet prevails over Medtrum in France patent spat

July 27, 2023 By Sean Whooley

Insulet France insulin pump patent Medtrum TouchCare Nano
Left: a diagram of the Insulet insulin pump patent in question. Top right: The Insulet Omnipod 5. Bottom right: The Medtrum TouchCare Nano.

According to a report in Europe, a Paris court found that Medtrum’s latest insulin pumps infringe an Insulet (Nasdaq:PODD) patent.

JUVE Patent reported that earlier this month, the Judicial Court of Paris declared the infringement. The court found that Medtrum’s newest pump base and patch reservoir models violate the EP2438957B1 patent from Insulet.

In declaring the infringement, the court ordered Medtrum to recall its Nano TouchCare pumps sold in France. Patients already using the device received an exemption.

China-based Medtrum describes itself as “a company dedicated to simplifying the management of diabetes.” It develops and delivers medical devices including pumps and glucose monitors. Medtrum also aims to produce an artificial pancreas system.

Among its offerings are the EasyPatch, a tubeless pump controlled with a smartphone app. The TouchCare Nano CGM monitors glucose levels and sends data to a smart device. Medtrum’s TouchCare Nano insulin pump is, like the Insulet Omnipod platform, a tubeless, wearable patch pump. It integrates with the CGM and smart devices to form the TouchCare Nano hybrid closed-loop automated insulin delivery system.

Insulet’s infringed patent describes the device as one for delivering fluid to a patient. It features an exit port assembly, a reservoir, a plunger and a sensor, among several other details. The company filed the patent in 2001.

According to JUVE Patent, the win in France for Insulet follows a determination in Germany that Medtrum’s A7+ model infringes the same patent. A Düsseldorf court ordered Medtrum’s subsidiaries to cease and desist, render accounts, recall and destroy infringing products and pay damages for past infringement. The outlet reports no other legal proceedings between the companies.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Patient Monitoring, Technology Tagged With: Insulet, Medtrum

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS